| [1] |
HAN Xue-fei;GUO Ying;ZHANG Hong;YAN Yan;XUE Shou-ru.
Clinical observation of immunomodulatory treatments for myasthenia gravis
[J]. CLINICAL FOCUS, 2013, 28(12): 1355-1357.
|
| [2] |
ZHANG Qing;YUAN Ning-lu.
Changes of T cell subsets in peripheral blood of myasthenia gravia patients and clinic significance
[J]. CLINICAL FOCUS, 2013, 28(9): 997-999.
|
| [3] |
.
[J]. Clinical Focus, 2012, 27(22): 1999-0.
|
| [4] |
.
[J]. CLINICAL FOCUS, 2010, 25(17): 1548-0.
|
| [5] |
YU Ning;XIE Bing-di;AN Zhong-ping.
Neurophysiological abnormalities in myasthenia gravis with thymic hyperplasia and thymoma
[J]. CLINICAL FOCUS, 2010, 25(2): 115-118.
|
| [6] |
.
[J]. CLINICAL FOCUS, 2009, 24(2): 182-184.
|
| [7] |
.
[J]. CLINICAL FOCUS, 2008, 23(18): 1348-0.
|
| [8] |
.
[J]. CLINICAL FOCUS, 2008, 23(12): 843-843.
|
| [9] |
.
[J]. CLINICAL FOCUS, 2008, 23(5): 363-363.
|
| [10] |
.
[J]. CLINICAL FOCUS, 2008, 23(1): 30-31.
|
| [11] |
.
[J]. CLINICAL FOCUS, 2006, 21(24): 1773-1774.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2006, 21(17): 1248-1249.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2006, 21(14): 996-996.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2005, 20(21): 1206-1206.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2005, 20(20): 1186-1186.
|
